Regulatory News:
TME Pharma N.V. , a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment , announced today that the annual.
Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME) (Paris:ALTME),a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment